Form D · Other Health Care

Daymark Health, Inc.

Philadelphia, PA · CIK 0002034499

Offering snapshot reported Sep 3, 2025 · SEC filing

Reported sold
$26M
Offering amount: $26M
Investors reported
7
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Aug 19, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 3, 2025Initial$26,000,000No comparison7SEC filing
Mar 14, 2025Initial$6,000,000No comparison2SEC filing
Aug 26, 2024Initial$5,500,027No comparison3SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
$0
Finders' fees
$0
Form D file number
021-556542
Total Offering Amount includes $6,000,000 of convertible securities.

Source: Form D, filed Sep 3, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Justin Bekelman Director, Executive
Matt Bettonville Director
Roy Beveridge Director
Ambar Bhattacharyya Director
Paul Default Executive
Paul Dufault Executive
Alon Krashinsky Director, Executive
Brian Lovett Director
Kelsey Maguire Director
Aman Mahajan Director
Robert Pahlavan Director
Jonathan Rhodes Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
701 E. Cathedral Rd, Suite 45 #3067
Philadelphia, PA, 19128